To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial. It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB." –Dr. William Jacobs, Jr.

(Bronx, NY)—In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.

TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.

The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr. Ph.D., professor of microbiology and microbiology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences. (Photo by: Shaun W)

Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol.

"We hypothesized that TB bacteria that can't make mycothiol might contain more cysteine, an amino acid," said Dr. Jacobs. "So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected."

The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a "reducing agent" that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.

"To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C," said Dr. Jacobs. "The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains."

To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial," said Dr. Jacobs. "It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB."

The paper is titled, "Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction." The other contributors are Catherine Vilcheze, Ph.D., Travis Hartman and Brian Weinrick, Ph.D., all at Einstein.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Young Men Flocking Back to Church in Search of Truth, Says Bestselling Author Jeremiah Johnston

Trans Insanity: Montana's Top Court Says It's Unconstitutional for Driver's Licenses to Say Men Are Men

ActBlue Is Toast, and Democrats Now Have a Massive Problem

DNI Tulsi Gabbard Exposes Conspiracy Used by Congress to Impeach Trump during First Term

Fraud Report: California 'Lost' $425 BILLION, and the Audit Starts... Never

Polls Open in Virginia Congressional Redistricting Vote Which Could Give Democrats a 10-1 Edge if Passed

Prayer Alert: Wildfires Increase across Florida to More Than 100

Israel Marks Memorial Day, Jewish Leaders Sign Apology Letter, as Clock Ticks on 2 Ceasefires

President Trump Calls for IRGC's Release of 8 Women They Plan to Execute

America Reads the Bible' Kicks Off in DC in Record-Breaking Fashion

Sweden Rethinks Digital Learning, Returns to 'Old-Fashioned' Books in Effort to Reverse Poor Literacy

Supreme Court Rejects Parents' Challenge to Massachusetts School Trans Policy

Gay Couple Face Online Fury for Video Making Fun of Crying Baby: 'There Is No Mama'

The Electoral College and the Popular Vote

The DOJ Has Found HOW MANY Dead People on Voter Rolls?

President Donald Trump to Read Scripture during America Reads the Bible; Issues Historic Message About the Bible's 'Enduring Guidance'

US Military Boards Iranian Ship in Gulf; Trump Threatens No More 'Mr. Nice Guy' if Talks Fail

Long Beach, California Cancels Their Popular July 4th Fireworks Show, Even for America's 250th Birthday, Citing Pollution as the Reason

Digital Nightmare? Anthropic Withholds AI Model Too Dangerous for Humanity

'A Victory for All Pro-Life Oregonians': Federal Judge Rules State Can't Force Oregon Right to Life to Pay for Abortions

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor